News

Certain types of skin cancers and blindness due to age-related macular degeneration (AMD) and diabetic retinopathy are likely to be among the first uses for the drug. The

Results from Dendreon’s pivotal phase III study (D9901) of Provenge (sipuleucel-T) were published in the Journal of Clinical Oncology. The double-blind, placebo-controlled study showed that the group of

Lucentis was specifically developed for intraocular use in the eye to treat the underlying cause of ‘wet’ age-related macular degeneration (AMD) by targeting the molecular pathway that controls

In a large, population-based study comparing risk factors in people with and without colorectal cancer, the researchers found the highest risk of colon cancer to be among long-term

The study was carried out by researchers from the Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins University School of Medicine. It determined that, in

The study, the biggest of its kind, analyzed information from a register of over 4,000 people aged up to 29 years diagnosed with type 1 diabetes over a

Metabolic syndrome is a group of conditions that increase the risk for heart disease, stroke and diabetes. The conditions include high blood pressure, excess body fat around the

The Rochester study is the first to compare gabapentin (marketed as Neurontin by Pfizer) and estrogen head-to-head against a placebo. Although it showed a substantial placebo effect similar

Under the agreement, Janssen will have exclusive rights in Europe, South America, the Middle East, Africa and Australia, and Vertex will retain exclusive commercial rights to VX-950 in